rapid growth Rapid Growth Projected for CLIA Analysers Market in India India's CLIA analyzers market poised for 6% CAGR growth by 2033, driven by disease testing and public health needs. Strategic collaborations like Fujirebio & Agappe's aim to boost local manufacturing and improve patient care.
News ACSS2 Inhibition Boosts TNBC Treatment Potential ACSS2 inhibition represents a significant breakthrough in the fight against Triple-Negative Breast Cancer (TNBC). This cutting-edge approach is unlocking new avenues for more effective and targeted treatments.
